LPS induces ferroptosis of lung epithelial cells. by Yaping Yuan (2734228)

Subjects:

Overexpression of <i>FBLN1</i> can inhibit ferroptosis in LPS-induced ALI. by Yaping Yuan (2734228)

Subjects:

Schematic diagram of the mechanism by which curcumin ameliorates aging-induced TJ damage in SCs. by Chen Xue (699418)

Subjects:

D-gal-induced aging leads to reduced autophagy levels in SCs, which are restored by curcumin <i>in vitro.</i> by Chen Xue (699418)

Subjects:

FBLN1 regulates ferroptosis by inhibiting TGF-β. by Yaping Yuan (2734228)

Subjects:

Curcumin restores D-gal-induced SCs TJ injury through autophagy activation <i>in vitro.</i> by Chen Xue (699418)

Subjects:

Digital Microfluidic Platform Based on Printed Circuit Board for Affinity Evaluation of Mertansine Aptamers by Dongliu Xiang (10688647)

“…Compared with manual methods, the digital microfluidic platform not only reduced the time for a single determination from 105 to 45 min but also significantly decreased the reagent consumption from 1280 to 30.72 μL. …”

Mean concentrations of sum monoterpenes and single monoterpenes: α-pinene, β-pinene, myrcene, limonene, β-(E)-ocimene, and α-terpineol obtained from the 10 distillation time (DT) f... by Valtcho D. Zheljazkov (627617)

Data Sheet 4_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.xlsx by Nana Wang (533812)

Data Sheet 2_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.xlsx by Nana Wang (533812)

Data Sheet 3_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.xlsx by Nana Wang (533812)

Data Sheet 1_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.xlsx by Nana Wang (533812)

Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis by Lin Y.-T. (17065287)

“…Echocardiographic parameters showed no significant changes. However, serum albumin and hemoglobin levels increased slightly but significantly after the transition, and the number of antihypertensive medications was also reduced. …”

Isotype control overlays. by Chen Lu (135200)

“…In bone marrow derived mesenchymal stem cells treated rats, the morbidity and mortality of decompression markedly decreased. The increases of protein IL-1 and IL-6 in BALF and lung wet/dry ratio and lung injury score were alleviated. …”

Original uncropped blot. by Chen Lu (135200)

“…In bone marrow derived mesenchymal stem cells treated rats, the morbidity and mortality of decompression markedly decreased. The increases of protein IL-1 and IL-6 in BALF and lung wet/dry ratio and lung injury score were alleviated. …”

Raw Data. by Chen Lu (135200)

“…In bone marrow derived mesenchymal stem cells treated rats, the morbidity and mortality of decompression markedly decreased. The increases of protein IL-1 and IL-6 in BALF and lung wet/dry ratio and lung injury score were alleviated. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Determinants of institutional delivery for women who had a live birth one year before the survey, NDHS 2022. by Resham B. Khatri (10949429)

Subjects: